We have updated our Privacy Policy. Please review our Privacy Policy. This website uses cookies. By using our website without changing your cookie settings you agree to our use of cookies as described in our Privacy Policy.

Click Here for Indications VIVITROL is indicated for:
  • The treatment of alcohol dependence in patients who are able to abstain from alcohol in an outpatient setting prior to initiation of treatment with VIVITROL. Patients should not be actively drinking at the time of initial VIVITROL administration.
  • The prevention of relapse to opioid dependence, following opioid detoxification.

VIVITROL should be part of a comprehensive management program that includes psychosocial support.

VIVITROL is a once-monthly treatment option1
VIVITROL® packaging

VIVITROL is an extended-release, microsphere formulation of naltrexone designed to be administered by deep gluteal injection every 4 weeks or once a month

  • Approximately 2 hours after injection, a transient initial naltrexone plasma concentration peak occurs, followed by a second peak approximately 2-3 days later
  • Beginning approximately 14 days after dosing, concentrations slowly decline, with measurable levels for greater than 1 month
  • Compared to daily oral dosing with naltrexone 50 mg over 28 days, total naltrexone exposure is 3- to 4-fold higher following administration of a single dose of VIVITROL 380 mg

Dosage and Administration

  • VIVITROL must be prepared and administered by a healthcare provider
  • VIVITROL must ONLY be administered as a deep intramuscular gluteal injection
  • Prior to initiation of VIVITROL, an opioid-free duration of a minimum of 7-10 days is recommended for patients, to avoid precipitation of opioid withdrawal that may be severe enough to require hospitalization
  • The recommended dose of VIVITROL is 380mg delivered intramuscularly (deep) as a gluteal injection every 4 weeks or once a month, alternating buttocks for each subsequent injection, using carton components provided

Please see Dosing and Administration page for full Dosing Information.

return to top

Reference: 1. VIVITROL [prescribing information]. Waltham, MA: Alkermes, Inc; rev March 2021.

return to top

Reference: 1. VIVITROL [prescribing information]. Waltham, MA: Alkermes, Inc; rev March 2021.

return to top